Harris Erik
Insider CIK 1780113 · RZLT Director · RARE EVP & Chief Commercial Officer · INZY Director · DNLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-04-16 | 2026-04-20 | 49,960 | — | $0 | 49,960 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-04-16 | 2026-04-20 | 28,895 | — | $0 | 118,410 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 10,539 | $22.80 | $240.3K | 89,515 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-03-01 | 2026-03-03 | 11,643 | — | $0 | 99,498 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2025-11-19 | 2025-11-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RZLT Rezolute, Inc. | A Award | 2025-11-19 | 2025-11-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| RZLT Rezolute, Inc. | A Award deriv | 2025-03-25 | 2025-03-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-03 | 2025-03-04 | 15,103 | $42.10 | $635.8K | 87,855 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-03-01 | 2025-03-04 | 30,246 | — | $0 | 30,246 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 16,813 | — | $0 | 83,976 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 18,443 | — | $0 | 102,419 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-10-03 | 2024-10-07 | 56,000 | — | $0 | 56,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 17,052 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 34,200 | — | $0 | 34,200 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 19,400 | — | $0 | 70,681 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 957 | — | $0 | 71,638 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-03-01 | 2024-03-05 | 4,768 | $53.76 | $256.3K | 67,163 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-09-05 | 2023-09-06 | 6,000 | $37.96 | $227.8K | 51,281 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-06-19 | 2023-06-21 | 305 | $48.20 | $14.7K | 57,281 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 11,085 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-03-01 | 2023-03-03 | 39,400 | — | $0 | 39,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-03-01 | 2023-03-03 | 3,664 | $45.25 | $165.8K | 57,344 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 2,663 | — | $0 | 38,823 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 22,000 | — | $0 | 60,823 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-06-19 | 2022-06-22 | 295 | $54.78 | $16.2K | 36,160 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 24,900 | — | $0 | 24,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 14,000 | — | $0 | 36,317 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-01 | 2022-03-03 | 2,713 | $66.62 | $180.7K | 22,317 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-07 | 20,607 | — | $0 | 20,607 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-02-03 | 2022-02-07 | 6,869 | — | $0 | 6,869 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-14 | 2021-10-18 | 303 | $81.14 | $24.6K | 25,030 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-07-06 | 2021-07-08 | 375 | $91.53 | $34.3K | 25,333 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-06-21 | 2021-06-23 | 572 | $94.96 | $54.3K | 25,708 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-06-19 | 2021-06-23 | 437 | $94.63 | $41.4K | 26,280 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-07 | 2021-05-10 | 393 | $113.67 | $44.7K | 26,717 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-06 | 2021-05-10 | 307 | $113.68 | $34.9K | 27,110 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-04-20 | 2021-04-21 | 396 | $104.28 | $41.3K | 27,417 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-02 | 2021-03-03 | 707 | $138.16 | $97.7K | 27,813 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 4,636 | — | $0 | 30,990 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-01 | 2021-03-03 | 2,470 | $138.17 | $341.3K | 28,520 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 5,500 | — | $0 | 26,354 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-14 | 2020-10-16 | 220 | $88.00 | $19.4K | 23,370 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-07-06 | 2020-07-08 | 260 | $86.75 | $22.6K | 23,590 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-06-19 | 2020-06-22 | 303 | $78.22 | $23.7K | 23,850 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-06-03 | 2021-02-03 | 2,516 | $74.69 | $187.9K | 20,854 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 209 | $66.26 | $13.8K | 24,153 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-04-19 | 2020-04-21 | 210 | $58.57 | $12.3K | 24,362 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-03-01 | 2020-03-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 824 | $56.08 | $46.2K | 24,572 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 3,287 | — | $0 | 25,396 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 7,800 | — | $0 | 22,109 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 1,208 | — | $0 | 14,309 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-07-06 | 2019-07-09 | 260 | $59.51 | $15.5K | 13,101 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-06-19 | 2019-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-06-19 | 2019-06-21 | 3,500 | — | $0 | 13,361 | SEC↗ |